Cellatoze Therapeutics focuses on developing innovative therapies that leverage its proprietary technology platform to address unmet medical needs. The company specializes in creating targeted treatments that enhance the delivery and efficacy of therapeutic agents. By utilizing advanced drug delivery systems, Cellatoze aims to improve patient outcomes in various disease areas, particularly those that require precise targeting to minimize side effects and maximize therapeutic benefits.

The core of Cellatoze's technology lies in its ability to formulate biologics and small molecules in a way that optimizes their pharmacokinetics and biodistribution. This includes the use of novel carriers and formulations that facilitate better absorption and targeted release of drugs within the body. The company’s research emphasizes the importance of understanding the underlying biology of diseases to develop tailored therapies that can effectively address specific patient needs, thereby advancing the field of precision medicine.

South Korea

Cellatose Therapeutics Co., Ltd. is a company specializing in cell therapy development that was established in August 2017 with the goal of ‘ resolving unmet needs for incurable diseases . ’ The nation's best cell therapy research and development experts are gathering to discover differentiated cell and platform technologies and promote the commercialization of cell therapy products.

Cellatoze Therapeutics

Company Details